Information:
Fel:
ID
23704
Beskrivning
The Clinical and Economic Impact of Pharmacogenomic Testing for Tamoxifen Metabolism in Postmenopausal Women Receiving Tamoxifen for Prevention of Recurrent Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00830973
Länk
https://clinicaltrials.gov/show/NCT00830973
Nyckelord
Versioner (1)
- 2017-07-11 2017-07-11 -
Uppladdad den
11 juli 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Breast Neoplasms NCT00830973
Eligibility Breast Neoplasms NCT00830973
- StudyEvent: Eligibility
Similar models
Eligibility Breast Neoplasms NCT00830973
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Pharmacy Benefit Clinical trial participant
Item
patient currently has a pharmacy benefit with medco for an enrolled client
boolean
C0031322 (UMLS CUI [1,1])
C0010187 (UMLS CUI [1,2])
C1997894 (UMLS CUI [1,3])
C0010187 (UMLS CUI [1,2])
C1997894 (UMLS CUI [1,3])
Tamoxifen | Insurance, Pharmaceutical Services
Item
patient has a adjudicated tamoxifen pharmacy claims within the last six months
boolean
C0039286 (UMLS CUI [1])
C0021691 (UMLS CUI [2])
C0021691 (UMLS CUI [2])
Tamoxifen | Prevention Breast cancer recurrent
Item
patient is still taking tamoxifen to prevent recurrent breast cancer
boolean
C0039286 (UMLS CUI [1])
C2700409 (UMLS CUI [2,1])
C0278493 (UMLS CUI [2,2])
C2700409 (UMLS CUI [2,1])
C0278493 (UMLS CUI [2,2])
Postmenopausal state | Age
Item
patient is a natural postmenopausal women 50 years of age or older
boolean
C0232970 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C0001779 (UMLS CUI [2])
Informed Consent
Item
patient signs consent
boolean
C0021430 (UMLS CUI [1])
Sample Provide Genetic testing
Item
patient is willing to provide sample for genetic testing
boolean
C0370003 (UMLS CUI [1,1])
C1999230 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
C1999230 (UMLS CUI [1,2])
C0679560 (UMLS CUI [1,3])
Tamoxifen | Pharmacogenetic Test Willing
Item
physician managing tamoxifen therapy is willing to order pharmacogenetic test
boolean
C0039286 (UMLS CUI [1])
C2347500 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
C2347500 (UMLS CUI [2,1])
C0600109 (UMLS CUI [2,2])
Gender
Item
patient is male
boolean
C0079399 (UMLS CUI [1])
Age
Item
patient is under 50 years old
boolean
C0001779 (UMLS CUI [1])
Cytochrome P-450 2D6 Testing
Item
patient has previous history of cyp450 2d6 testing
boolean
C0057223 (UMLS CUI [1,1])
C0039593 (UMLS CUI [1,2])
C0039593 (UMLS CUI [1,2])
Tamoxifen Discontinued
Item
patient is no longer taking tamoxifen
boolean
C0039286 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C1444662 (UMLS CUI [1,2])
Informed Consent Refused
Item
patient refuses to sign consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
C1705116 (UMLS CUI [1,2])
Participation Continue Unwilling | Testing Status post
Item
patient wishes to no longer participate after testing
boolean
C0679823 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0039593 (UMLS CUI [2,1])
C0231290 (UMLS CUI [2,2])
C0549178 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
C0039593 (UMLS CUI [2,1])
C0231290 (UMLS CUI [2,2])
Pharmacogenetic Test Refused
Item
patient's physician refuses to order pharmacogenetic test
boolean
C2347500 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
C1705116 (UMLS CUI [1,2])